Modeling Long Sequences in Bladder Cancer Recurrence: A Comparative Evaluation of LSTM,Transformer,and Mamba
Traditional survival analysis methods often struggle with complex time-dependent data,failing to capture and interpret dynamic characteristics adequately.This study aims to evaluate the performance of three long-sequence models,LSTM,Transformer,and Mamba,in analyzing recurrence event data and integrating them with the Cox proportional hazards model.This study integrates the advantages of deep learning models for handling long-sequence data with the Cox proportional hazards model to enhance the performance in analyzing recurrent events with dynamic time information.Additionally,this study compares the ability of different models to extract and utilize features from time-dependent clinical recurrence data.The LSTM-Cox model outperformed both the Transformer-Cox and Mamba-Cox models in prediction accuracy and model fit,achieving a Concordance index of up to 0.90 on the test set.Significant predictors of bladder cancer recurrence,such as treatment stop time,maximum tumor size at recurrence and recurrence frequency,were identified.The LSTM-Cox model aligned well with clinical outcomes,effectively distinguishing between high-risk and low-risk patient groups.This study demonstrates that the LSTM-Cox model is a robust and efficient method for recurrent data analysis and feature extraction,surpassing newer models like Transformer and Mamba.It offers a practical approach for integrating deep learning technologies into clinical risk prediction systems,thereby improving patient management and treatment outcomes.
Code (0)
등록된 구현이 없습니다.
Tasks
MambaSurvival AnalysisMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
H-CNN-ViT: A Hierarchical Gated Attention Multi-Branch Model for Bladder Cancer Recurrence Prediction
Bladder cancer is one of the most prevalent malignancies worldwide, with a recurrence rate of up to 78%, necessitating accurate post-operative monitoring for effective patient management. Multi-sequence contrast-enhanced…
Reviewing AI's Role in Non-Muscle-Invasive Bladder Cancer Recurrence Prediction
Notorious for its 70-80% recurrence rate, Non-muscle-invasive Bladder Cancer (NMIBC) imposes a significant human burden and is one of the costliest cancers to manage. Current tools for predicting NMIBC recurrence rely on…
ManagementRedefining cystoscopy with ai: bladder cancer diagnosis using an efficient hybrid cnn-transformer model
Bladder cancer ranks within the top 10 most diagnosed cancers worldwide and is among the most expensive cancers to treat due to the high recurrence rates which require lifetime follow-ups. The primary tool for diagnosis …
Computational EfficiencyDiagnosticNMGrad: Advancing Histopathological Bladder Cancer Grading with Weakly Supervised Deep Learning
The most prevalent form of bladder cancer is urothelial carcinoma, characterized by a high recurrence rate and substantial lifetime treatment costs for patients. Grading is a prime factor for patient risk stratification,…
Multiple Instance LearningAI-Based Clinical Rule Discovery for NMIBC Recurrence through Tsetlin Machines
Bladder cancer claims one life every 3 minutes worldwide. Most patients are diagnosed with non-muscle-invasive bladder cancer (NMIBC), yet up to 70% recur after treatment, triggering a relentless cycle of surgeries, moni…